Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Gene Therapy|August 12, 2008
Gene therapy for multiple myelomaYasuo Adachi, Naoko Yoshio-Hoshino, Norihiro NishimotoCurrent Pharmaceutical Design|May 14, 2008
The blockade of IL-6 signaling in rational drug designYasuo Adachi, Naoko Yoshio-Hoshino, Norihiro NishimotoArthritis and Rheumatism|April 3, 2008
Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibodyNorihiro Nishimoto, Hideko Nakahara, Naoko Yoshio-Hoshino, et al.Anticancer Research|July 24, 2010
VEGF targeting in mesotheliomas using an interleukin-6 signal inhibitor based on adenovirus gene deliveryYasuo Adachi, Naoko Yoshio-Hoshino, Chieko Aoki, et al.Modern Rheumatology|September 3, 2008
A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 yearsHideko Nakahara, Toru Mima, Naoko Yoshio-Hoshino, et al.Cancer Research|February 7, 2007
Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumorNaoko Yoshio-Hoshino, Yasuo Adachi, Chieko Aoki, et al.International Journal of Cancer|April 28, 2006
Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomasYasuo Adachi, Chieko Aoki, Naoko Yoshio-Hoshino, et al.Arthritis Research & Therapy|January 6, 2009
Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosusHooi-Ming Lee, Toru Mima, Hidehiko Sugino, et al.Pageof 1